Anna-Maria Georgoudaki
Senior R&D Manager Glycostem Therapeutics
Seminars
Wednesday 2nd December 2026
Advancing Allogeneic CD19 Targeting Strategies to Enable Reliable Immune Reset in Autoimmune Disease
1:30 pm
- Presenting preclinical data demonstrating B-cell targeting in SLE
- Exploring allogeneic off-the-shelf approaches to improve scalability
- Outlining strategies to translate preclinical findings into clinical development
